Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.

Schettini J, Kidiyoor A, Besmer DM, Tinder TL, Roy LD, Lustgarten J, Gendler SJ, Mukherjee P.

Cancer Immunol Immunother. 2012 Nov;61(11):2055-65. doi: 10.1007/s00262-012-1264-y. Epub 2012 Apr 28.

2.

Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer.

Roy LD, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P.

BMC Cancer. 2011 Aug 22;11:365. doi: 10.1186/1471-2407-11-365.

3.

Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.

Besmer DM, Curry JM, Roy LD, Tinder TL, Sahraei M, Schettini J, Hwang SI, Lee YY, Gendler SJ, Mukherjee P.

Cancer Res. 2011 Jul 1;71(13):4432-42. doi: 10.1158/0008-5472.CAN-10-4439. Epub 2011 May 10.

4.

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.

Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P.

Oncogene. 2011 Mar 24;30(12):1449-59. doi: 10.1038/onc.2010.526. Epub 2010 Nov 22.

5.

Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model.

Pinkhasov J, Alvarez ML, Pathangey LB, Tinder TL, Mason HS, Walmsley AM, Gendler SJ, Mukherjee P.

Cancer Immunol Immunother. 2010 Dec;59(12):1801-11. doi: 10.1007/s00262-010-0906-1. Epub 2010 Sep 8.

6.

Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.

Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P.

Breast Cancer Res. 2009;11(4):R56. doi: 10.1186/bcr2345. Epub 2009 Jul 30.

7.

Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

Mukherjee P, Basu GD, Tinder TL, Subramani DB, Bradley JM, Arefayene M, Skaar T, De Petris G.

J Immunol. 2009 Jan 1;182(1):216-24.

8.

MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.

Tinder TL, Subramani DB, Basu GD, Bradley JM, Schettini J, Million A, Skaar T, Mukherjee P.

J Immunol. 2008 Sep 1;181(5):3116-25.

9.

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.

Mukherjee P, Pathangey LB, Bradley JB, Tinder TL, Basu GD, Akporiaye ET, Gendler SJ.

Vaccine. 2007 Feb 19;25(9):1607-18. Epub 2006 Nov 16.

10.

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

Basu GD, Tinder TL, Bradley JM, Tu T, Hattrup CL, Pockaj BA, Mukherjee P.

J Immunol. 2006 Aug 15;177(4):2391-402.

11.

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.

Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P.

Breast Cancer Res. 2005;7(4):R422-35. Epub 2005 Apr 4.

12.

Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model.

Mukherjee P, Tinder TL, Basu GD, Pathangey LB, Chen L, Gendler SJ.

Breast Dis. 2004;20:53-63. Review.

PMID:
15687707
13.

Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

Basu GD, Pathangey LB, Tinder TL, Lagioia M, Gendler SJ, Mukherjee P.

Mol Cancer Res. 2004 Nov;2(11):632-42.

14.

MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.

Mukherjee P, Tinder TL, Basu GD, Gendler SJ.

J Leukoc Biol. 2005 Jan;77(1):90-9. Epub 2004 Oct 28.

PMID:
15513966
15.

MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment.

Mukherjee P, Ginardi AR, Madsen CS, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ.

Glycoconj J. 2001 Nov-Dec;18(11-12):931-42.

PMID:
12820727
16.

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.

Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ.

J Immunother. 2003 Jan-Feb;26(1):47-62.

PMID:
12514429
17.

MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo.

Mukherjee P, Ginardi AR, Tinder TL, Sterner CJ, Gendler SJ.

Clin Cancer Res. 2001 Mar;7(3 Suppl):848s-855s.

PMID:
11300482

Supplemental Content

Loading ...
Support Center